acetylcysteine has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bray, SM; Chang, S; He, C; Jin, P; Li, Z; Warren, ST; Zarnescu, DC | 1 |
Gass, JT; Kalivas, PW; Lavin, A; Moran, M; Moussawi, K; Olive, MF; Pacchioni, A | 1 |
2 other study(ies) available for acetylcysteine and 6-methyl-2-(phenylethynyl)pyridine
Article | Year |
---|---|
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila.
Topics: Animals; Disease Models, Animal; Drosophila; Drosophila Proteins; Drug Evaluation, Preclinical; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; gamma-Aminobutyric Acid; Glutamic Acid; Male; Molecular Weight; Mutation; Phenotype; Pyridines; RNA, Messenger; Small Molecule Libraries | 2008 |
N-Acetylcysteine reverses cocaine-induced metaplasticity.
Topics: Acetylcysteine; Animals; Behavior, Animal; Cocaine-Related Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Free Radical Scavengers; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Neuronal Plasticity; Nucleus Accumbens; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Secondary Prevention; Self Administration; Substance Withdrawal Syndrome | 2009 |